THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Initial report clears Parexel

Probe of injuries during tests hints problem was drug

By Stephen Heuser
Globe Staff / April 6, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Investigators in Britain have ruled out contamination, overdose, and procedural problems in the case of an experimental biotechnology drug that sent six patients to the intensive care unit of a London hospital last month. (Full article: 530 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass